DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer

Summary

The purpose of this trial is to study DPPE combined with epirubicin and cyclophosphamide in patients with metastatic and/or recurrent breast cancer who may have received previous hormone treatment but have not had exposure to anthracycline treatment. Stratification allocation will be within the following subgroups: 1. Prior cytotoxic treatment; 2. Estrogen receptor status; 3. ECOG performance status; 4. Number of cycles of chemotherapy.

Timeline

Start

2004-05

Primary completion

—

Completion

2006-06

Drugs

Indications